Kynam Capital Management, LP Q4 2023 Filing
Filed February 14, 2024
Portfolio Value
$902.6B
Holdings
24
Report Date
Q4 2023
Filing Type
13F-HR
All Holdings (24 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | NTRANATERA INC | 2,400,000 | $150K | 0.00% | |
| 2 | SNDXSYNDAX PHARMACEUTICALS INC | 5,660,000 | $122K | 0.00% | |
| 3 | TCE2CELLDEX THERAPEUTICS INC NEW | 3,005,904 | $119K | 0.00% | |
| 4 | PCVXVAXCYTE INC | 1,002,407 | $62K | 0.00% | |
| 5 | VERAVERA THERAPEUTICS INC | 3,650,339 | $56K | 0.00% | |
| 6 | PTGXPROTAGONIST THERAPEUTICS INC | 2,004,875 | $45K | 0.00% | |
| 7 | IMGNEURIMMUNOGEN INC | 1,422,503 | $42K | 0.00% | |
| 8 | MOR2MORPHOSYS AG | 4,234,685 | $41K | 0.00% | |
| 9 | COGTCOGENT BIOSCIENCES INC | 5,854,766 | $34K | 0.00% | |
| 10 | LQDALIQUIDIA CORPORATION | 2,698,324 | $32K | 0.00% | |
| 11 | BCRXBIOCRYST PHARMACEUTICALS INC | 4,600,000 | $27K | 0.00% | |
| 12 | TSVT*2SEVENTY BIO INC | 5,953,825 | $25K | 0.00% | |
| 13 | DVAXDYNAVAX TECHNOLOGIES CORP | 1,514,383 | $21K | 0.00% | |
| 14 | HTDCORCEPT THERAPEUTICS INC | 585,900 | $19K | 0.00% | Put |
| 15 | WVEWAVE LIFE SCIENCES LTD | 3,932,082 | $19K | 0.00% | |
| 16 | TVTXTRAVERE THERAPEUTICS INC | 2,000,000 | $17K | 0.00% | |
| 17 | VRDNVIRIDIAN THERAPEUTICS INC | 607,915 | $13K | 0.00% | |
| 18 | AMRNAMARIN CORP PLC | 12,022,957 | $10K | 0.00% | |
| 19 | STROSUTRO BIOPHARMA INC | 2,001,727 | $8K | 0.00% | |
| 20 | SLRNACELYRIN INC | 1,200,000 | $8K | 0.00% | |
| 21 | BNRBURNING ROCK BIOTECH LTD | 8,694,426 | $8K | 0.00% | |
| 22 | CRBUCARIBOU BIOSCIENCES INC | 1,068,527 | $6K | 0.00% | |
| 23 | TYRATYRA BIOSCIENCES INC | 340,190 | $4K | 0.00% | |
| 24 | CNTACENTESSA PHARMACEUTICALS PLC | 442,704 | $3K | 0.00% |